Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000597749 | SCV000704801 | uncertain significance | not provided | 2016-12-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002315891 | SCV000848249 | likely benign | Inborn genetic diseases | 2022-05-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000597749 | SCV003459075 | benign | not provided | 2024-11-13 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005027703 | SCV005661462 | likely benign | ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder | 2024-05-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003945402 | SCV004766169 | likely benign | ADNP-related disorder | 2022-11-09 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |